Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2017 (2017), Article ID 8401518, 8 pages
https://doi.org/10.1155/2017/8401518
Research Article

Factors Associated with the Prevalence of Thyroid Nodules and Goiter in Middle-Aged Euthyroid Subjects

1Institute of Endocrinology, Medical Academy, Lithuanian University of Health Sciences, Kaunas, Lithuania
2Faculty of Public Health, Medical Academy, Lithuanian University of Health Sciences, Kaunas, Lithuania
3Department of Endocrinology, Medical Academy, Lithuanian University of Health Sciences, Kaunas, Lithuania

Correspondence should be addressed to Dalia Dauksiene

Received 18 September 2016; Revised 17 December 2016; Accepted 4 January 2017; Published 5 March 2017

Academic Editor: Sabrina Corbetta

Copyright © 2017 Dalia Dauksiene et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Andersson, B. Takkouche, I. Egli, H. E. Allen, and B. De Benoist, “Current global iodine status and progress over the last decade towards the elimination of iodine deficiency,” Bulletin of the World Health Organization, vol. 83, no. 7, pp. 518–525, 2005. View at Google Scholar
  2. M. J. Welker and D. Orlov, “Thyroid nodules,” American Family Physician, vol. 67, no. 3, pp. 559–566, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. L. Zheng, W. Yan, Y. Kong, P. Liang, and Y. Mu, “An epidemiological study of risk factors of thyroid nodule and goiter in Chinese women,” International Journal of Clinical and Experimental Medicine, vol. 8, no. 7, pp. 11379–11387, 2015. View at Google Scholar
  4. P. Laurberg, N. Knudsen, S. Andersen, A. Carle, I. B. Pedersen, and J. Karmisholt, “Thyroid function and obesity,” European Thyroid Journal, vol. 1, no. 3, pp. 159–167, 2012. View at Publisher · View at Google Scholar
  5. G. L. Roef, E. R. Rietzschel, C. M. Van Daele et al., “Triiodothyronine and free thyroxine levels are differentially associated with metabolic profile and adiposity-related cardiovascular risk markers in euthyroid middle-aged subjects,” Thyroid, vol. 24, no. 2, pp. 223–231, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Ayturk, A. Gursoy, A. Kut, C. Anil, A. Nar, and N. B. Tutuncu, “Metabolic syndrome and its components are associated with increased thyroid volume and nodule prevalence in a mild-to-moderate iodine-deficient area,” European Journal of Endocrinology, vol. 161, no. 4, pp. 599–605, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. H. Y. Yasar, O. Ertugrul, B. Ertugrul, D. Ertugrul, and M. Sahin, “Insulin resistance in nodular thyroid disease,” Endocrine Research, vol. 36, no. 4, pp. 167–174, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. C. Anil, A. Akkurt, S. Ayturk, A. Kut, and A. Gursoy, “Impaired glucose metabolism is a risk factor for increased thyroid volume and nodule prevalence in a mild-to-moderate iodine deficient area,” Metabolism, vol. 62, no. 7, pp. 970–975, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. E. Blanc, C. Ponce, D. Brodschi et al., “Association between worse metabolic control and increased thyroid volume and nodular disease in elderly adults with metabolic syndrome,” Metabolic Syndrome and Related Disorders, vol. 13, no. 5, pp. 221–226, 2015. View at Publisher · View at Google Scholar · View at Scopus
  10. N. Knudsen, P. Laurberg, H. Perrild, I. Bülow, L. Ovesen, and T. Jørgensen, “Risk factors for goiter and thyroid nodules,” Thyroid, vol. 12, no. 10, pp. 879–888, 2002. View at Publisher · View at Google Scholar
  11. W. M. Wiersinga, “Smoking and thyroid,” Clinical Endocrinology, vol. 79, no. 2, pp. 145–151, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Petkeviciene, J. Klumbiene, S. Simonyte et al., “Physical, behavioural and genetic predictors of adult hypertension: the findings of the Kaunas Cardiovascular Risk Cohort study,” PloS One, vol. 9, no. 10, Article ID e109974, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Petkeviciene, J. Klumbiene, V. Kriaucioniene, A. Raskiliene, E. Sakyte, and I. Ceponiene, “Anthropometric measurements in childhood and prediction of cardiovascular risk factors in adulthood: Kaunas cardiovascular risk cohort study,” BMC Public Health, vol. 15, no. 1, p. 218, 2015. View at Publisher · View at Google Scholar · View at Scopus
  14. D. Matthews, J. Hosker, A. Rudenski, B. Naylor, D. Treacher, and R. Turner, “Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man,” Diabetologia, vol. 28, no. 7, pp. 412–419, 1985, http://www.ncbi.nlm.nih.gov/pubmed/3899825 View at Publisher · View at Google Scholar · View at Scopus
  15. P. Laurberg, I. Bülow Pedersen, N. Knudsen, L. Ovesen, and S. Andersen, “Environmental iodine intake affects the type of nonmalignant thyroid disease,” Thyroid, vol. 11, no. 5, pp. 457–469, 2001. View at Publisher · View at Google Scholar
  16. V. F. H. Brauer, W. H. Brauer, D. Führer, and R. Paschke, “Iodine nutrition, nodular thyroid disease, and urinary iodine excretion in a German university study population,” Thyroid, vol. 15, no. 4, pp. 364–370, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. R. Gärtner, “Recent data on iodine intake in Germany and Europe,” Journal of Trace Elements in Medicine and Biology, vol. 37, pp. 85–89, 2016. View at Publisher · View at Google Scholar
  18. P. Vejbjerg, N. Knudsen, H. Perrild et al., “Effect of a mandatory iodization program on thyroid gland volume based on individuals’ age, gender, and preceding severity of dietary iodine deficiency: a prospective, population-based study,” The Journal of Clinical Endocrinology and Metabolism, vol. 92, no. 4, pp. 1397–1401, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. F. A. Lombardi, E. Fiore, M. Tonacchera et al., “The effect of voluntary iodine prophylaxis in a small rural community: the pescopagano survey 15 years later,” The Journal of Clinical Endocrinology and Metabolism, vol. 98, no. 3, pp. 1031–1039, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. F. Delange, A. Robertson, E. McLoughney, and G. Gerasimov, in Elimination of Iodine Deficiency Disorders (IDD) in Central and Eastern Europe, the Commonwealth of Independent States, and the Baltic States, World Health Organization, Munich, Germany, 1998.
  21. Lietuvos Respublikos Apsaugos Ministro, in Dėl Lietuvos Higienos Normos HN 15:2003, Jsakymo no. V-392, 2003, Lietuvos Respublikos Sveikatos Apsaugos Ministro, “Maisto Higiena Tvirtinimo Pakeitimo,” Jsakymas no. V-255, 2004.
  22. V. Šidlauskas and A. Šlapikienė, “Data of the thyroid sonographic volumetry among Lithuanian population,” Lietuvos Endokrinologija, vol. 6, pp. 10–12, 1999. View at Google Scholar
  23. Y. Fleury, G. Van Melle, V. Woringer, R. C. Gaillard, and L. Portmann, “Sex-dependent variations and timing of thyroid growth during puberty,” The Journal of Clinical Endocrinology and Metabolism, vol. 86, no. 2, pp. 750–754, 2001. View at Publisher · View at Google Scholar
  24. M. Rotondi, G. Amato, B. Biondi et al., “Parity as a thyroid size-determining factor in areas with moderate iodine deficiency,” The Journal of Clinical Endocrinology and Metabolism, vol. 85, no. 12, pp. 4534–4537, 2000. View at Publisher · View at Google Scholar
  25. N. Knudsen, I. Bülow, P. Laurberg, L. Ovesen, H. Perrild, and T. Jørgensen, “Parity is associated with increased thyroid volume solely among smokers in an area with moderate to mild iodine deficiency,” European Journal of Endocrinology, vol. 146, no. 1, pp. 39–43, 2002. View at Publisher · View at Google Scholar
  26. M. F. T. Wesche, W. M. Wiersinga, and N. J. Smits, “Lean body mass as a determinant of thyroid size,” Clinical Endocrinology, vol. 48, no. 6, pp. 701–706, 1998. View at Publisher · View at Google Scholar · View at Scopus
  27. Y. Zou, G. Ding, X. Lou et al., “Factors influencing thyroid volume in Chinese children,” European Journal of Clinical Nutrition, vol. 67, no. 11, pp. 1138–1141, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Turcios, J. J. Lence-Anta, J. L. Santana et al., “Thyroid volume and its relation to anthropometric measures in a healthy Cuban population,” European Thyroid Journal, vol. 4, no. 1, pp. 55–61, 2015. View at Publisher · View at Google Scholar
  29. P. Kayastha, S. Paudel, D. Shrestha, R. Ghimire, and S. Pradhan, “Study of thyroid volume by ultrasonography in clinically euthyroid patients,” Journal of Institute Medicine, vol. 32, no. 2, pp. 36–43, 2010. View at Google Scholar
  30. J. Steinberger, D. R. Jacobs, S. Raatz, A. Moran, C. P. Hong, and A. R. Sinaiko, “Comparison of body fatness measurements by BMI and skinfolds vs dual energy X-ray absorptiometry and their relation to cardiovascular risk factors in adolescents,” International Journal of Obesity, vol. 29, no. 11, pp. 1346–1352, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. M. H. Lee, J. U. Lee, K. H. Joung et al., “Thyroid dysfunction associated with follicular cell steatosis in obese male mice and humans,” Endocrinology, vol. 156, no. 3, pp. 1181–1193, 2015. View at Publisher · View at Google Scholar · View at Scopus
  32. H. Jiang, Y. Tian, W. Yan et al., “The prevalence of thyroid nodules and an analysis of related lifestyle factors in Beijing communities,” International Journal of Environmental Research and Public Health, vol. 13, no. 4, p. 442, 2016. View at Publisher · View at Google Scholar · View at Scopus
  33. L. Hegedüs, S. J. Bonnema, and F. N. Bennedbæk, “Management of simple nodular goiter: current status and future perspectives,” Endocrine Reviews, vol. 24, no. 1, pp. 102–132, 2003. View at Publisher · View at Google Scholar · View at Scopus
  34. G. Popoveniuc and J. Jonklaas, “Thyroid nodules,” Medical Clinics of North America, vol. 96, no. 2, pp. 329–349, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. W. C. Kung, M. T. Chau, T. T. Lao, S. C. F. Tam, and L. C. K. Low, “The effect of pregnancy on thyroid nodule formation,” The Journal of Clinical Endocrinology and Metabolism, vol. 87, no. 3, pp. 1010–1014, 2002. View at Publisher · View at Google Scholar
  36. B. Rapoport, G. D. Chazenbalk, J. C. Jaume, and S. M. McLachlan, “The thyrotropin (TSH) receptor: interaction with TSH and autoantibodies,” Endocrine Reviews, vol. 19, no. 6, pp. 673–716, 1998. View at Publisher · View at Google Scholar
  37. A. O. Duran, C. Anil, A. Gursoy et al., “Thyroid volume in patients with glucose metabolism disorders,” Arquivos Brasileiros de Endocrinologia e Metabologia, vol. 58, no. 8, pp. 824–827, 2014. View at Publisher · View at Google Scholar · View at Scopus
  38. S. Ertek, A. F. G. Cicero, O. Caglar, and G. Erdogan, “Relationship between serum zinc levels, thyroid hormones and thyroid volume following successful iodine supplementation,” Hormones, vol. 9, no. 3, pp. 263–268, 2010. View at Publisher · View at Google Scholar
  39. P. A. M. De Sousa, M. Vaisman, J. R. I. Carneiro et al., “Prevalence of goiter and thyroid nodular disease in patients with class III obesity,” Arquivos Brasileiros de Endocrinologia e Metabologia, vol. 57, no. 2, pp. 120–125, 2013. View at Publisher · View at Google Scholar · View at Scopus
  40. V. Vella, L. Sciacca, G. Pandini et al., “The IGF system in thyroid cancer: new concepts,” Molecular Pathology, vol. 54, no. 3, pp. 121–124, 2001. View at Publisher · View at Google Scholar · View at Scopus
  41. G. Medeiros-Neto and M. Knobel, “Iodine deficiency disorders,” Endocrinology 6th Ed. Chapter 88, Elsevier, New York, 2010, Medeiros. View at Google Scholar
  42. M. R. Haymart, D. J. Repplinger, G. E. Leverson et al., “Higher serum thyroid stimulating hormone level in thyroid nodule patients is associated with greater risks of differentiated thyroid cancer and advanced tumor stage,” The Journal of Clinical Endocrinology and Metabolism, vol. 93, no. 3, pp. 809–814, 2008. View at Publisher · View at Google Scholar · View at Scopus
  43. E. Fiore and P. Vitti, “Serum TSH and risk of papillary thyroid cancer in nodular thyroid disease,” Journal of Clinical Endocrinology and Metabolism, vol. 97, no. 4, pp. 1134–1145, 2012. View at Publisher · View at Google Scholar · View at Scopus
  44. J. Rezzonico, M. Rezzonico, E. Pusiol, F. Pitoia, and H. Niepomniszcze, “Introducing the thyroid gland as another victim of the insulin resistance syndrome,” Thyroid, vol. 18, no. 4, pp. 461–464, 2008. View at Publisher · View at Google Scholar · View at Scopus
  45. T. Kimura, A. Van Keymeulen, J. Golstein, A. Fusco, J. E. Dumont, and P. P. Roger, “Regulation of thyroid cell proliferation by tsh and other factors: a critical evaluation of in vitro models,” Endocrine Reviews, vol. 22, no. 5, pp. 631–656, 2001. View at Publisher · View at Google Scholar
  46. N. Knudsen, I. Bülow, P. Laurberg, L. Ovesen, H. Perrild, and T. Jørgensen, “Association of tobacco smoking with goiter in a low-iodine-intake area,” Archives of Internal Medicine, vol. 162, no. 4, pp. 439–443, 2002. View at Publisher · View at Google Scholar
  47. M. R. Galanti, F. Granath, S. Cnattingius, A. Ekbom-Schnell, and A. Ekbom, “Cigarette smoking and the risk of goitre and thyroid nodules amongst parous women,” Journal of Internal Medicine, vol. 258, no. 3, pp. 257–264, 2005. View at Publisher · View at Google Scholar · View at Scopus
  48. N. Knudsen, I. Bülow, P. Laurberg, H. Perrild, L. Ovesen, and T. Jørgensen, “High occurrence of thyroid multinodularity and low occurrence of subclinical hypothyroidism among tobacco smokers in a large population study,” The Journal of Endocrinology, vol. 175, no. 3, pp. 571–576, 2002. View at Publisher · View at Google Scholar · View at Scopus
  49. K. Petersen, G. Lindstedt, P. A. Lundberg, C. Bengtsson, L. Lapidus, and E. Nyström, “Thyroid disease in middle-aged and elderly Swedish women: thyroid-related hormones, thyroid dysfunction and goitre in relation to age and smoking,” Journal of Internal Medicine, vol. 229, no. 5, pp. 407–413, 1991. View at Publisher · View at Google Scholar
  50. H. Fukayama, M. Nasu, S. Murakami, and M. Sugawara, “Examination of antithyroid effects of smoking products in cultured thyroid follicles: only thiocyanate is a potent antithyroid agent,” Acta Endocrinologica, vol. 127, no. 6, pp. 520–525, 1992. View at Publisher · View at Google Scholar
  51. C. S. Tam, W. Xie, W. D. Johnson, W. T. Cefalu, L. M. Redman, and E. Ravussin, “Defining insulin resistance from hyperinsulinemic-euglycemic clamps,” Diabetes Care, vol. 35, no. 7, pp. 1605–1610, 2012. View at Publisher · View at Google Scholar · View at Scopus